Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer

International Journal of Gynecological Cancer

Volumn 15, Issue 4, 2005, Pages 624-629

  Roos, E J ^a   Van Eijkeren, M A ^a   Boon, T A ^a   Heintz, A P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Complications; Gynecologic cancer; Pelvic exenteration; Survival; Urologic cancer

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; EXPERIENCE; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; PELVIS CANCER; PELVIS EXENTERATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SURVIVAL; URINARY TRACT CANCER; URINARY TRACT INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; MORBIDITY; PELVIC EXENTERATION; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UROLOGIC NEOPLASMS;

EID: 22544483529     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00118.x     Document Type: Article

References (15)

1. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-83.
2. Heintz APM, Allen DG. Practical procedures for the gynaecologic oncologist. Amsterdam Elsevier Science, 1998:87-98.
3. Anthopoulus AP, Manetta A, Larson JE, Podczaski ES, Bartholomew MJ, Mortel R. Pelvic exenteration: a morbidity and mortality analysis of a seven year experience. Gynecol Oncol 1989;35:219-23.
4. Robertson G, Lopes A, Beyon G, Monaghan JM. Pelvic exenteration: a review of Gateshead experience 1974-1992. Br J Obstet Gynaecol 1994;101:529-31.
5. Lopez MJ, Standiford SB, Skibba JL. Total pelvic exenteration. A 50-year experience at the Ellis Fischel Cancer Center. Archiv Surg 1994;129:390-6.
6. Roderiquez-Bigas MA, Petrelli NJ. Pelvic exenteration and its modifications. Am J Surg 1996;171:293-301.
7. Morely GW, Hopkins MP, Lindenauer SM, Roberts JA. Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 1989;74:934-43.
8. Lawhead RA, Clark DGC, Smith DH, Pierce VK, Lewis JL. Pelvic exenteration for recurrent or persistent gynaecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981). Gynecol Oncol 1989;33:379-82.
9. Franchi M, Donadello N. Pelvic exenteration in gynaecologic oncology: review. Eur J Gynaecol Oncol 1994; 15:469-74.
10. Averette HE, Lichtinger M, Seven BU. Pelvic exenteration: a 15-years experience in a general metropolitan hospital. Am J Obstet Gynecol 1984;150:179-83.
11. Matthews CM, Morris M, Burke TW, Gershenson DM, Taylor Wharton J, Rutledge FN. Pelvic exenteration in the elderly patient. Obstet Gynecol 1992;79:773-7.
12. Sheperd JH, Ngan HY, Neven P, Fryatt I, Woodhouse CR, Hendry WF. Multivariate analysis of factors affecting survival in pelvic exenteration. Int J Gynecol Cancer 1994;4:361-70.
13. Crowe PJ, Temple WT, Lopez MJ, Ketcham AS. Pelvic exenteration for advanced pelvic malignancy. Semin Surg Oncol 1999;17:152-60.
14. Soper JT, Berchuck A, Creasman WT, Clarke-Pearson DL. Pelvic exenteration: factors associated with major surgical morbidity. Gynecol Oncol 1989;35:93-8.
15. Rutledge FN, McGuffee MA. Pelvic exenteration: prognostic significance of regional lymph node metastasis. Gynecol Oncol 1987;26:374-80.